Neupogen

Links to news articles on Neupogen .

Man Convicted for Role in South Florida Drug Adulteration Ring, US ... -- Mar 28, 2006
Prescription drugs sold by the crime ring included Neupogen, used for cancer and HIV patients; Gammagard (Gamimune, Iveegam and Panglobulin), used for HIV ... Lawfuel (press release),

Guilty verdict in AIDS drug scam -- Mar 28, 2006
Medications such as Epogen, a drug for kidney dialysis and cancer patients, and Neupogen, used for cancer and HIV patients, were diluted, relabeled and sold to ... Miami Herald,

Demand to expand -- Mar 28, 2006
...found effective in slowing tumor growth in patients with colorectal cancer. ... to boost capacity for drugs produced there -- Epogen, Aranesp, Neupogen and Neulasta ... TMCnet

Long-Term Study Shows Safety of Neupogen® in AML Treatment -- Mar 17, 2006
However, there have been questions about whether Neupogen or Neulasta can increase the risk of cancer recurrences and ultimately survival in patients with ... Cancer Consultants (press release),

A sister's gift of love -- Mar 27, 2006
...when Anna settles into a hematology suite at Detroit's Karmanos Cancer Institute tomorrow. ... Anna received shots of the drug neupogen for four days to stimulate ... Cheboygan Daily Tribune (subscription),

Long-Term Study Shows Safety of Neupogen® Support in AML ... -- Mar 17, 2006
Researchers affiliated with The International Acute Myeloid Leukemia Study have reported that the use of Neupogen (filgrastim) to support intensive induction ... Cancer Consultants (press release),

Dacogen™ Improves Outcomes in Myelodysplastic Syndromes -- Mar 15, 2006
2] This study appeared in an early online publication in Cancer on March 10 ... EPO) and granulocyte colony stimulating factors (G-CSF, Neupogen®) are improving ... Cancer Consultants (press release),

March is National Nutrition Month: Introducing The Annie Appleseed ... -- Mar 3, 2006
...burn and poison.’ In addition, each of these conventional cancer treatments can ... the need for very expensive “rescue drugs,�? such as Procrit and Neupogen. ... PR Web (press release),

A Lisa Pierot tribute: Part 6: 2004-2005 -- Mar 3, 2006
My white counts plummeted, and so they gave me multiple shots of Neupogen to bring ... riding a roller coaster of emotions since the news that my cancer is back. ... Palm Beach Post,

RQ-PCR Positivity Predicts Relapse of Mantle Cell Lymphoma after ... -- Mar 9, 2006
Stem cells were mobilized with chemotherapy and Neupogen® and all but one patent had stem ... Overall, MRD by PCR was a strong predictor of a cancer recurrence. ... Cancer Consultants (press release),

Heart-attack patients not helped by Amgen drug -- Mar 1, 2006
...in Thousand Oaks. Neupogen is used by cancer patients undergoing chemotherapy to build up their white blood cells, which help them fight infection. ... Ventura County Star (subscription),

US Study Fails to Confirm Benefits of Autologous Stem Cell ... -- Mar 14, 2006
This study called for VAD (vincristine, Adriamycin and dexamethasone) induction and cyclophosphamide/Neupogen® mobilization of peripheral blood stem cells in ... Cancer Consultants (press release),

Mobilizing bone marrow stem cells doesn't repair heart, study ... -- Feb 28, 2006
...to receive injections of a placebo or Neupogen, a bone marrow-stimulating drug widely used to spur replacement of white blood cells after cancer chemotherapy. ... Grand Forks Herald,

Amgen to add 150 Seattle jobs -- 25 Jan 2006
...including Enbrel, a treatment approved for rheumatoid arthritis and psoriasis, and Neupogen, a product designed to reduce infection in certain cancer patients. Seattle Post Intelligencer

Earnings Preview: Johnson & Johnson -- Jan 23, 2006
...that Amgen penalizes cancer clinics by requiring the purchase of Aranesp for good deals on its white blood-cell growth drugs Neulasta and Neupogen, which face ... BusinessWeek

Drug duo offers new hope in the fight against cancer -- Dec 26, 2005
Once the cancer is eliminated, the stem cells can be returned intravenously ... Doctors have routinely given transplant patients a drug called Neupogen to coax the ... Centre Daily Times,

Autologous Stem Cell Transplants: Less Toxic Consolidation Therapy ... -- Jan 10, 2006
...daunomycin. Autologous peripheral blood stem cells were harvested after cytarabine, daunomycin and Neupogen® (filgrastim). Table ... Cancer Consultants (press release),

Superiority of Alkeran®, Thalidomid® Prednisone Regimen for ... -- Jan 5, 2006
...or a regimen of VAD (vincristine, doxorubicin, dexamethasone) followed by mobilization of stem cells with cyclophosphamide and Neupogen® (filgrastim) and ... Cancer Consultants (press release),

Thalidomide Improves Initial—not Overall—Response Rate in ... -- Dec 29, 2005
...assigned to receive three cycles of VAD versus three cycles of TAD, followed by CAD (cyclophosphamide, doxorubicin, and dexamethasone) with Neupogen® for the ... Cancer Consultants (press release),

Drug duo: New hope in cancer fight -- Dec 18, 2005
Once the cancer is eliminated, the stem cells can be returned intravenously ... Doctors have routinely given transplant patients a drug called Neupogen to coax the ... Macon Telegraph,

Abraxane™ Safe When Used in Dose-Dense Therapy Regimen for ... -- Dec 19, 2005
...for early breast cancer. Twenty-seven out of 29 patients were able to receive Abraxane, with one-third of these patients receiving Neupogen® (filgrastim). ... Cancer Consultants (press release),

Long-Term Safety of Dose-Dense Adjuvant Chemotherapy for Breast ... -- Dec 8, 2005
...with Neupogen® (filgrastim) was well tolerated and may have improved outcomes in some subsets of women receiving adjuvant chemotherapy for breast cancer. ... Cancer Consultants (press release),

No Long-Term Adverse Effects of Neupogen® Given After Allogeneic ... -- Dec 13, 2005
Researchers affiliated with the International Bone Marrow Transplant Registry (IBMTR) have reported that the administration of Neupogen (filgrastim) following ... Cancer Consultants (press release),

Tandem High-Dose Chemotherapy Superior to Dose-Dense Chemotherapy ... -- Dec 5, 2005
...short interval between therapy is a valid concept for treating breast cancer. ... and platelets while current growth factor therapy with Neupogen® (filgrastim) or ... Cancer Consultants (press release),

High-dose Chemotherapy Plus Growth Factor Helps in Locally ... -- Dec 2, 2005
...axillary lymph nodes who were randomly assigned to accelerated high-dose chemotherapy plus Neupogen (filgrastim) support ... "Patients with breast cancer that has ... MedPage Today,

Former pharmacy owner sent to prison -- Dec 10, 2005
...drugs Procrit and Epogen. They also included Neupogen, which prevents infections in patients undergoing certain cancer treatments. ... The Journal News.com,

Aranesp® Effective in Low and Intermediate Risk Myelodysplastic ... -- Dec 7, 2005
...were available to one in which the supportive growth factors erythropoietin (EPO) and granulocyte colony stimulating factors (G-CSF, Neupogen®) are improving ... Cancer Consultants (press release),

Biotech Earnings Jump In Quarter -- 21 Nov 2005
...$215 million was aided by unapproved use as an adjuvant in breast cancer therapy ... And combined sales of the infection fighters Neulasta and Neupogen enjoyed a 17 ... Chemical & Engineering News

Neupogen® Plus Antibiotics Decrease Febrile Neutropenia in Small ... -- Nov 8, 2005
...of Neupogen (granulocyte-colony stimulating factor) to prophylactic antibiotics decreases febrile neutropenia in patients with small cell lung cancer (SCLC ... Cancer Consultants (press release),

Prophylactic G-CSFs May Reduce Infection-Related Mortality -- Nov 11, 2005
...may reduce the risk of infection-related mortality in cancer patients. The results of analyzing 10 randomized trials, nine involving Neupogen® (filgrastim) or ... Cancer Consultants (press release),

Dose-Dense Navelbine® and Taxotere® with Neupogen® Support for ... -- Oct 21, 2005
Administration of drugs every two weeks (dose-dense) is usually accomplished with Neupogen support. In the case of breast cancer, dose-dense regimens appear ... Cancer Consultants (press release),

Dose-Dense Chemotherapy Regimen for Non-Small Cell Lung Cancer -- Oct 25, 2005
Treatment of advanced non-small cell lung cancer with dose-dense Navelbine® (vinorelbine) and Taxotere® (docetaxel), coupled with Neupogen® (filgrastim) to ... Cancer Consultants (press release),

Innovative Drug Tarceva Now Available in Europe to Tackle Growing ... -- Oct 30, 2005
...bone metastases, hypercalcaemia of malignancy), Kytril (for chemotherapy and radiotherapy-induced nausea and vomiting), Neupogen (for cancer-related neutropenia ... Antara,

Amgen Beats Estimates But Drops On Revenue Numbers -- Oct 20, 2005
Neulasta and Neupogen work by selectively stimulating the production of ... in suppressing pathologic bone turnover in patients with metastatic breast cancer. ... BioWorld Online (subscription),

Amgen's Third Quarter 2005 Adjusted Earnings Per Share Increased ... -- Oct 19, 2005
Combined sales of Neulasta and NEUPOGEN in the United States were $680 ... cell booster helps protect patients with most types of cancer undergoing moderately ... Business Wire (press release),

Amgen's 3rd-Qtr Profit Rose to $967 Mln Helped by Aranesp Sales -- Oct 19, 2005
J&J's lawsuit in US District Court in Trenton, New Jersey, alleges that Amgen gave cancer clinics bigger discounts on Neulasta and Neupogen if they bought ... Bloomberg

Amgen earnings quadruple because of special charges -- Oct 19, 2005
Neulasta and Neupogen boost white blood cell production and help fight infections in cancer patients. For the quarter, combined ... San Jose Mercury News,

Amgen's earnings surge for quarter -- Oct 20, 2005
Neulasta and Neupogen boost production of white blood cells and help fight infections in cancer patients. For the quarter, combined ... Philadelphia Inquirer,

Amgen Profit Jumps, Revenue Disappoints -- Oct 19, 2005
Sales of Aranesp, which is used to treat anemia in cancer and kidney dialysis ... Combined worldwide sales of Neulasta and Neupogen rose 17 percent to $882 million ... Los Angeles Business Journal,

UPDATE 1-Amgen 3rd-quarter profit jumps on drug sales -- Oct 19, 2005
Sales of Aranesp, used to treat anemia in cancer and kidney dialysis patients ... Combined worldwide sales of Neulasta and Neupogen, used to boost white blood cells ... Reuters

Amgen quarterly profit up, but sales lag -- Oct 19, 2005
Combined worldwide sales of Neulasta and Neupogen, used to boost white blood cells to ... a string of impressive successes in clinical studies of its cancer drugs. ... Herald News Daily,

Amgen's Drive to Diversify -- Oct 20, 2005
...and earnings. Neupogen and Neulasta help cancer patients undergoing chemotherapy maintain white blood cell counts. Aranesp is designed ... Motley Fool

Amgen's earnings quadruple over 2004 -- Oct 20, 2005
Johnson & Johnson's Procrit competes with Aranesp to treat anemia in cancer patients ... An earlier version, Neupogen, held about even with the year before at $305 ... Ventura County Star (subscription),

More information on Neupogen from the National Cancer Institute

Biological therapy is a type of treatment that works with your immune system. It can help fight cancer or help control side effects (how your body reacts to the drugs you are taking) from other cancer treatments like chemotherapy.

What is the difference between biological therapy and chemotherapy?

Biological therapy and chemotherapy are both treatments that fight cancer. While they may seem alike, they work in different ways. Biological therapy helps your immune system fight cancer. Chemotherapy attacks the cancer cells directly.

How does biological therapy fight cancer?

Doctors are not sure how biological therapy helps your immune system fight cancer. But they think it may:

Stop or slow the growth of cancer cells.
Make it easier for your immune system to destroy, or get rid of, cancer cells.
Keep cancer from spreading to other parts of your body.